1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Wilcoxon test comparing percentage change in DN/pons and GP/pons ratios from study 1 to study 7 between the gadobutrol and linear groups
Group No. Percentage Change (Mean) SD Median Lower Quartile Upper Quartile
DN/Pons 
    Gadobutrol (group 1) 59 −0.80 4.78 −0.66 −4.24 2.21
    Linear GBCAs (group 2) 60 3.10 5.56 3.70 −0.52 6.76
GP/Pons 
    Gadobutrol (group 1) 59 −0.30 5.44 0.72 −3.56 2.26
    Linear GBCAs (group 2) 60 2.47 6.53 2.05 −2.56 6.48

Group	No.	Percentage Change (Mean)	SD	Median	Lower Quartile	Upper Quartile
DN/Pons
Gadobutrol (group 1)	59	−0.80	4.78	−0.66	−4.24	2.21
Linear GBCAs (group 2)	60	3.10	5.56	3.70	−0.52	6.76
GP/Pons
Gadobutrol (group 1)	59	−0.30	5.44	0.72	−3.56	2.26
Linear GBCAs (group 2)	60	2.47	6.53	2.05	−2.56	6.48